SCHEMBL7988482

SCHEMBL7988482

CCCc1nc2ncn(Cc3cccc(F)c3)c2c(=O)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE1C Q14123 1/20 0.46
HPGD P15428 3/20 0.45
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KMT2A Q03164 1/20 0.44
HCAR2 Q8TDS4 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
KDM1A O60341 1/20 0.41
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
KDM4E B2RXH2 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984206 0.91 HPGD (0.46) PDE1APDE1BPDE1CHPGDALDH1A1
SCHEMBL7988531 0.89 ALDH1A1 (0.44) PDE1APDE1BPDE1CHPGDALDH1A1
SCHEMBL7988657 0.88 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7991723 0.87 SMN1; SMN2 (0.49) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7988953 0.87 HPGD (0.45) HPGDALDH1A1SMN1; SMN2KMT2AKDM4E
SCHEMBL7989405 0.87 SMN1; SMN2 (0.57) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7989507 0.86 HPGD (0.46) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7984130 0.85 GAA (0.52) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2
SCHEMBL7988487 0.83 PDE1A (0.46) PDE1APDE1BPDE1CHPGDALDH1A1
SCHEMBL7985859 0.82 CNOT7 (0.49) HPGDALDH1A1SMN1; SMN2KMT2AHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed